The effect of seeing a family physician on the level of glycosylated hemoglobin (HbA1c) in type 2 Diabetes Mellitus patients by Ali Reza Mahdavi et al.
Mahdavi et al. Journal of Diabetes & Metabolic Disorders 2013, 12:2
http://www.jdmdonline.com/content/12/1/2RESEARCH ARTICLE Open AccessThe effect of seeing a family physician on the
level of glycosylated hemoglobin (HbA1c) in type
2 Diabetes Mellitus patients
Ali Reza Mahdavi1, Koorosh Etemad1, Muhiuddin Haider2 and Seyed Mohammad Alavinia3*Abstract
Background: Glycosylated hemoglobin (HbA1c) in diabetic patients reflects the average blood glucose level, and
will not be affected by variability in blood glucose in short time. Regular care of patients by medical staff could
effectively control glycemic situation. The aim of this study was to assess the effect of medical care by general
physicians on glycemic control by measuring of HbA1c.
Methods: In order to assess the effectiveness of National program for diabetes control and prevention in Iran, we
compare HbA1c, Fasting blood glucose (FBS), systolic and diastolic blood pressure in two groups of diabetic
patients diagnosed in this program. The first group consisted of patients who received at least four visits by General
Physician (GP) during one year after the diagnosis, and second group were patients who did not visited by GPs or
received 1–3 visits.
Results: After one year, 24.1% of patients did not receive any care, while 57.9% examined at least once a year.
Among visited patients, 23.5% received 1–3 times medical care and 23.5% received four or more visits. HbA1c was
significantly lowered in patients with appropriate care (four and more) compared with the non cared patients and
patients with less than four cares.
Conclusion: Appropriate number of visits for each patient by GPs is an effective glycemic control in diabetic
patients. Although this study provides a framework for medical care in diabetes, how to take care of these patients
depends on specific situation of each patient and should be determined for each of them individually.
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According to the latest report by the World Health
Organization (WHO), the prevalence of diabetes in the
world will increase from 4% in 1995 to 5.4% in 2025. Fur-
ther, the population of diabetics in the world will increase
122%, from 132 million in 1995 to 300 million in 2025 [1].
Unfortunately, the WHO projects that deaths resulting
from diabetes will double between 2005 and 2030 [2]. The
total number of excess deaths attributable to diabetes
worldwide was estimated to be 3.96 million in the age
group 20–79 years, 6.8% of global (all ages) mortality [3].
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reproduction in any medium, provided the oryear 2000 was estimated to be 2.9 million deaths, equiva-
lent to 5.2% of all deaths. Excess mortality attributable to
diabetes accounted for 2–3% of deaths in poorest coun-
tries and over 8% in the U.S., Canada, and the Middle East.
In people 35–64 years old, 6–27% of deaths were attribut-
able to diabetes [4].
Diabetics are at a 15-times greater risk of amputations
than healthy individuals [5]. The findings from different
population based studies for measuring prevalence of dia-
betic retinopathy suggested that the prevalence of more
severe grades ranges from about 3% to 10% among diabetic
patients [6,7]. The prevalence of blindness in diabetics has
been reported in different studies and ranges from 0.4–1%
[8,9]. The diabetes control and complications trial demon-
strates that the general management of blood glucose
levels is important in reducing the progress of diabeticl Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 baseline characteristics of 1423patients identified
during screening and after 1 year
Mean ± Standard deviation P-
valueScreening One year later
BMI 28.25 ± 4.69 28.19 ± 4.68 1.60
Systolic Blood
Pressure(mmHg)
124.63 ± 18.25 129.29 ± 21.40 <0.001
Diastolic Blood
Pressure(mmHg)
75.51 ± 11.36 77.77 ± 11.86 <0.001
Mean arterial pressure 91.26 ± 12.17 94.25 ± 13.42 <0.001
Fasting blood sugar 204.30 ± 88.83 175.24 ± 69.71 <0.001
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nephropathy can be reduced by long-term control through
annual laboratory tests and prompt treatment of micro-
albuminuria [10].
Considering numerous long – term and serious com-
plications of diabetes, several problems and restrictions
of diabetes, such as ophthalmic, renal, vascular and ner-
vous disorders, which lead to blindness, severe renal
disease, amputation, Cerebrovascular accident (CVA)
and Myocardial Infarction(MI)-, will occur if appropri-
ate and prompt action concerning the prevention, con-
trol, and treatment of the disease is not taken. The
primary aim of this study was to compare the HbA1c
between those individuals with diabetes who have been
visited and cared for by a family physician at least four
times in the past twelve month in a rural health center
with patients who have not been visited by their family
physician within the past twelve months.
Methods
National program for diabetes control & prevention
in Iran
To prevent and control diabetes and its complications
in an early phase, Iran implemented the National Pro-
gram for Diabetes Control and Prevention. This pro-
gram was developed and implemented for the purposes
of screening ‘individuals at risk’, and pregnant women.
Individuals at risk consist of all people over 30 years old
who have at least one risk factor as positive family his-
tory of diabetes, hypertension, overweight or obesity.Table 2 comparison of HbA1c, FBS, BMI, and mean arterial bl
the end of first year of diagnosis of diabetes
Number No care
Mean ± SD
HbA1c 267 8.03 ± 2.25
Fasting Blood Sugar 273 174.11 ± 69.86
BMI 269 28.87 ± 4.89
Mean arterial pressure 267 97.59 ± 14.01Presently, the National Program for Diabetes Control
and Prevention has been integrated into the national
health system of Iran since 2004. The first stage of the
program was implemented in rural areas of Iran and
since then two rounds of screening have been held to
cover non-covered portions of the country.
Study population
In this study, 41 medical universities located within 30
provinces in Iran were responsible for providing health
care services to the population of interest, among them
11universities were selected randomly. Among the
diabetic patients, diagnosed in national program of
diabetes in these universities, 1,423 type 2 diabetic
patients were selected randomly proportional to the size
of diagnosed diabetic patients in each selected univer-
sity and followed from 2010 until 2011.
In the first step, patients were divided in two groups;
1-Patients who received any care in past 12 months by
family physicians; and 2- Patients who did not receive any
visits from a family physician. Then, we divided those
patients who received care according to the numbers of
medical visits during the first year following a diagnosis
with diabetes. Since in the National Program for Diabetes
Control and Prevention each GP has to visit diabetic
patients four times per year, the patients were grouped
depending on receiving one to three physician visits
during the first year and those who were visited four or
more times by their family general physicians. For each
patient a questionnaire was completed.
For those patients who received care, we compared
the fasting blood sugar (FBS), HbA1c, Body Mass Index
(BMI), systolic and diastolic blood pressure, and mean
arterial pressure in these two groups of patients at the
time of screening and after one year of diagnosis with
diabetes.
Measurements
Data on age, height, and weight were collected by the
questionnaire during the medical examination. BMI was
calculated by dividing body weight in kilogram by the
square of body height in meters and used to define sub-
jects as normal (BMI below 25), overweight (BMI fromood pressure in patients with and without care by GPs in
Number At least one care p-value
Mean ± SD
858 7.78 ± 2.15 0.10
861 172.04 ± 65.95 0.66
857 27.79 ± 4.56 0.001
858 93.64 ± 13.19 <0.001
Table 3 Mean and se HbA1c and FBS adjusted for age,
sex, BMI, and mean arterial pressure in diabetic patients





4 cares and more
(N = 595)
P-value
Age 57 ± 0.66 57 ± 0.76 56 ± 0.46 0.42
Female (%) 61 71 69 0.36
HbA1c 7.9 ± 0.14 8.1 ± 0.14 7.3 ± 0.09 <0.001*
FBS 157 ± 4.20 162 ± 4.02 153 ± 2.7 0.01
Mean arterial
pressure
93.55 ± 0.86 93.33 ± 0.82 92.89 ± 0.54 0.60
*statistically significant difference between 4 cares and more with no care
(p-value = 0.01) and 1–3 cares and more (p-value = 0.001).
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after filling out the questionnaire, all patients were
referred to the laboratory for measuring HbA1c and
FBS. All tests were performed in the same laboratory
and the chromatography method was used to measure
HbA1c.Statistical analysis
All descriptive data are given as mean ± standard
deviation, and as percentages when appropriate.
Analysis of covariance was done using general linear
model, comparing three groups of diabetic patients to
test difference in HbA1c adjusted for age, sex, BMI, and
mean arterial pressure. Bonferoni post hoc test was
applied to determine significant differences between spe-
cific groups on these variables. To compare the diffe-
rences between variables in the time of diagnosis and
1 year after that, the paired t-test has been used.
The independent t-test was applied for comparison of
FBS, BMI, and arterial pressure in two groups of
patients; the patients who received appropriate care
(at least 4 visits by GPs) and patients with no medical
care. The statistical analyses were carried out with SPSS
version 18.Table 4 comparison of mean systolic and diastolic blood
pressure, BMI, and FBS in the time of diagnosis of
diabetes and one year later in patients who have had
appropriate care (4 and more) by general practitioner
Mean ± Standard deviation P-
valueScreening One year later
BMI 27.88 ± 4.43 27.78 ± 4.50 0.24
Systolic Blood Pressure
(mmHg)
123.01 ± 16.93 126.81 ± 20.92 <0.001
Diastolic Blood Pressure
(mmHg)
75.44 ± 11.14 76.98 ± 11.4 <0.001
Fasting blood sugar 200.88 ± 83.13 171.52 ± 4.32 <0.001Results
Table 1 shows the baseline characteristics of the 1,423
diabetic patients obtained during the screening and
following one year of diagnosis. Among the patients, 421
(29.6%) were male and 1,002 (70.4%) were female. The
mean age of the patients was 57.36 years (SD = 11.40)
with a maximum age of 91 years. Information on the
number of visits by general physicians was available on
1,134 patients. Among this group, 273(24.1%) patients
did not receive any medical care, while 861(75.9%) were
visited at least one time by GPs within the first year
following a diagnosis of diabetes. Considering the num-
ber of visits, 266 (23.4%) patients were visited by their
GPs one to three times and 595(75.9%) were visited four
times or more. After one year of diagnosis, FBS
decreased significantly (P-value ≤ 0.001), while mean
arterial blood pressure rose dramatically (p-value ≤
0.001) in all patients. Table 2 shows the comparison of
HbA1c, FBS, BMI, and mean arterial blood pressure in
two groups of patients after one year of disease diagno-
sis. The comparison of HbA1c and FBS adjusted for age,
sex, and mean arterial pressure between the three
groups of patients in regard to the number of cares
showed a significant decrease in HbA1c in patients with
four or more cares (p-value < 0.001). There was no sta-
tistical significant difference in HbA1c between those
patients who received no care and those patients who
were visited one to three times by GPs (Table 3). Table 4
shows the comparison of systolic blood pressure,
diastolic blood pressure, BMI, and FBS at the time of
screening and follow-up within one year in patients who
have had appropriate care (four or more visits) by their
GPs.
Discussion
This study showed that the number of visits of diabetic
patients by a GP plays an important role and desirable
effect on controlling blood glucose and HbA1c, and
every diabetic patient should be visited at least four
times a year by their family physician. According to the
authors knowledge this is the first study that evaluates
the effect of number of medical care on diabetes control.
Tabrizi et al. in a review found that diabetes management
programs with focus on regular visits are significantly
related to better control of diabetes, reduced rates of
diabetes complications, and reduced hospital admission.
Other studies have also shown that improved of delivered
care in both clinical and non-clinical areas increases quality
of life and personal satisfaction and reduce the disease
complications as well as the overall burden of type 2
diabetes.
One of the reasons that patients do not refer to their
GP could be relate to quality of health care services. The
service should focus on adequate manpower, personal
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rule of procedure. These factors have a significant rela-
tionship with quality of care and patients' satisfaction.
Another reason is related to the effective communica-
tion between doctor and patient. Physician – patient
communication makes a significant difference to patient
health outcomes. Physician education was demonstrated
to affect the patients' emotional status, whereas patient
education was demonstrated to affect physical health, level
of function, blood pressure and blood glucose level. Good
communication between physician – could encourage
patients refer to the general physician in due time. Despite
all been told the exact reason for not referring patient to
their GP is not clear and should be studied in further
research.
Hypertension and diabetes co-exist frequently resul-
ting in significant mortality and morbidity. The preva-
lence of hypertension in diabetic patients is 1.5–2 times
higher than in general population [11]. Significant
increase in mean systolic and diastolic blood pressure in
patients during the year of the study may be related to
the fact that the physicians who being involved in the
program have paid more attention to diagnosis and
treatment of diabetes and miss other patients' problems.
It is also might be related to macro- and micro-vascular
complication of diabetes which makes hypertension
treatment more difficult. Despite higher mean blood
pressure of the patients in the end of the first year, dia-
stolic and systolic blood pressure of the patients who
had received at least four times visits by GPs (appropri-
ate care) were significantly lower than the other patients.
This finding emphasizes again the importance of medical
care by family physicians. The mean blood pressure was
increased in these patients when comparing with their
blood pressure at the beginning of the study.
The important issue that needs to be considered in
this regard is that when such a specific programs have
been implemented and executed, it is also necessary to
consider the patients' other health problems, and the
health care providers especially GPs should be trained
for appropriate management of co-existing problems.
One of the strengths of this study was the large study
population which caused greater precision of the results.
We also used the least number of medical laboratories
possible for testing in order to reduce the variation of
test results.
Based on the authors' knowledge there is no previous
study to evaluate the relationship between the number
of medical visits and blood glucose control in the dia-
betic patients. Masoudi-Alavia et.al in a Persian study
entitled “Effect of design and implementation of health
care model in diabetic patients” have declared that in
this model, individuals, management system, and social
security system are three systems interacting with eachothers that can cause good glycemic control in diabetic
patients. They emphasize the management system as an
important component for controlling the disease [12].
The limitation of the study was that the HbA1c was
not measured in diabetic patients in the beginning of the
study; therefore we compared the differences in HbA1c
in patients who received 1 to 3 visits during a year after
diabetes diagnosis with the patients who received at least
4 visits after one year. The patients were assigned in dif-
ferent groups randomly and there were no differences
between the different comparison groups of patients.Conclusion
At least four visits by GPs in diabetic patients are neces-
sary to effectively control the disease. Therefore, there is
essential that different interventions to be used for
encouraging patients to see their GPs regularly. The
finding of this study could be used in planning and po-
licy making for prevention and control of diabetes and
its complication and use as a guide for interventional
study in future in this field.
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